Tirzepatide 5mg 10mg 40mg

Description

Tirzepatide is a synthetic peptide designed to mimic the activity of gastric inhibitory polypeptide (GIP), while also exhibiting properties similar to glucagon-like peptide-1 (GLP-1). In research environments, Tirzepatide has been observed to influence glucose metabolism, support insulin sensitivity, and promote satiety. Studies suggest that this dual-action mechanism may also offer potential benefits for metabolic and cardiovascular function.

Research

– Tirzepatide is a synthetic peptide composed of 39 amino acids, designed to mimic the activity of gastric inhibitory polypeptide (GIP) while also activating GLP-1 (glucagon-like peptide-1) receptors. This dual-receptor action has been studied for its effects on insulin signaling, glucose metabolism, and metabolic regulation. In research settings, Tirzepatide has been associated with increased insulin sensitivity, reduced circulating insulin levels, and elevated adiponectin — a hormone linked to improved metabolic function. Additionally, research models have shown that Tirzepatide may significantly impact body weight regulation, with observed reductions of up to 11 kg (approximately 25 lbs) over extended study periods. These effects are believed to be related to enhanced satiety, reduced food intake, and improved glucose tolerance.